Skip to main content
. 2016 Jul 9;7(50):82213–82227. doi: 10.18632/oncotarget.10511

Table 1. Comparison of NFκB RelA, miR-146a-5p and SMAD4 between Epstein-Barr virus-positive and Epstein-Barr virus-negative stomach cancer.

EBV-positive EBV-negative
(n = 14) (n = 19) P value
NFκB RelA 0.080
 negative 9 (67%) 17 (90%)
 positive 5 (33%) 2 (10%)
miR-146a-5p 0.033
 mean / median 148.5/102.3 67.4/60.4
 (range) (38.0 ~ 483.6) (13.0 ~ 146.4)
SMAD4 0.580
 loss 7 (50%) 10 (53%)
 preserved 7 (50%) 9 (47%)